As the industry moves toward continuous bioprocessing, more effective ways are being developed to validate viral clearance. Researchers at Asahi Kasei Bioprocess America have developed a small-scale ...
More than 250 million people worldwide live with chronic hepatitis B (HBV), yet there is still no accessible animal model for studying the disease or testing novel therapies. Researchers have now ...
Liver cancer is one of the world's deadliest cancers, and most cases are linked to chronic viral hepatitis. Yet scientists have lacked an animal model that faithfully recapitulates how the disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results